Centenial Surgical Suture Ltd Share Price

Centenial Surgic
Small Cap | Healthcare
₹ 100.4 0.1 (0.1%)
Last updated: 05-Dec-2025 , 16:01:43

Centenial Surgical Suture Ltd Live Price Chart

Low: ₹100.4 High: 104.95

Centenial Surgical Suture Ltd Technicals

Current Price
₹ 100.4 0.1 (0.1%)
EMASMA
20 Day ₹ 103.496
50 Day ₹ 107.212
100 Day ₹ 114.459
200 Day ₹ 119.850
20 Day ₹ 102.760
50 Day ₹ 104.031
100 Day ₹ 121.921
200 Day ₹ 122.813

Centenial Surgical Suture Ltd Performance

Previous Close ₹ 100.3
High ₹ 104.95
Volume 123
52W Range ₹ 82.15 - ₹ 189
Open ₹ 102.8
Low ₹ 100.4
Market Cap 38.25 Cr

Centenial Surgical Suture Ltd Fundamentals

ROCE 1.957
P/E Ratio -17.580
P/B Ratio 1.270
Industry P/E 1.270
Debt to Equity 80.589
ROE -6.784
EPS -5.710
Dividend Yield 0.000
Book Value 79.265
Face Value 10.000

Centenial Surgical Suture Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 53.6363 51.3149 52.7847 44.4712 37.0256
Total Expenses 55.254 50.042 51.3218 43.3967 35.4957
Profit After Tax -1.4636 1.1343 0.8859 0.6271 0.9618

Centenial Surgical Suture Ltd Shareholding Pattern

Promoter Holdings 46.888 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 50.641 %
Others - 2.472 %

About Centenial Surgical Suture Ltd

History of Centenial Surgical Suture Ltd

Incorporated in 1995, Centenial Surgical Suture is engaged in the manufacture and sale of surgical sutures in India. The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes. It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Apollo Hospitals Enterprise Ltd ₹ 6001 - ₹ 8099.5 7193.05 73.74
Indraprastha Medical Corporation Ltd ₹ 307.25 - ₹ 640.85 472.9 24.81
Poly Medicure Ltd ₹ 1821.2 - ₹ 3031 1907.2 55.2
Max Healthcare Institute Ltd ₹ 940.05 - ₹ 1314.3 1097.95 166.36
Fortis Healthcare Ltd ₹ 577 - ₹ 1104.3 886 384.35

FAQs on Centenial Surgical Suture Ltd

1. Can I buy Centenial Surgical Suture Ltd from PL Capital? ›

Yes, you can invest in Centenial Surgical Suture Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Centenial Surgical Suture Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Centenial Surgical Suture Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Centenial Surgical Suture Ltd pay dividends? ›

Centenial Surgical Suture Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Centenial Surgical Suture Ltd ? ›

As of 05-12-2025 the share price for Centenial Surgical Suture Ltd. is 100.4 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Centenial Surgical Suture Ltd ? ›

The 52-week high and low of Centenial Surgical Suture Ltd share price is ₹ 82.15 - ₹ 189 as of 05-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source